Study Using Citrate to Replace Heparin in Babies Requiring Extracorporeal Membrane Oxygenation (ECMO)
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of citrate to provide
anticoagulation of an ECMO circuit without patient anticoagulation. The standard method of
providing ECMO circuit anticoagulation is the use of heparin which also anticoagulates the
patient and increases the risk of patient bleeding.
Phase:
Early Phase 1
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center